Shanghai OPM Revenue vs. Price To Book
| 688293 Stock | 39.71 0.21 0.53% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 243.1 M | Current Value 240.7 M | Quarterly Volatility 58.3 M |
For Shanghai OPM profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shanghai OPM to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shanghai OPM Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shanghai OPM's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shanghai OPM Biosciences over time as well as its relative position and ranking within its peers.
Shanghai |
Shanghai OPM Biosciences Price To Book vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai OPM's current stock value. Our valuation model uses many indicators to compare Shanghai OPM value to that of its competitors to determine the firm's financial worth. Shanghai OPM Biosciences is the top company in revenue category among its peers. It also is number one stock in price to book category among its peers . The ratio of Revenue to Price To Book for Shanghai OPM Biosciences is about 111,519,673 . At present, Shanghai OPM's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai OPM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai OPM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shanghai Revenue vs. Competition
Shanghai OPM Biosciences is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 8.73 Trillion. Shanghai OPM adds roughly 243.12 Million in revenue claiming only tiny portion of equities under Health Care industry.
Shanghai Price To Book vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Shanghai OPM |
| = | 243.12 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Shanghai OPM |
| = | 2.18 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Shanghai Price To Book Comparison
Shanghai OPM is currently under evaluation in price to book category among its peers.
Shanghai OPM Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Shanghai OPM, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shanghai OPM will eventually generate negative long term returns. The profitability progress is the general direction of Shanghai OPM's change in net profit over the period of time. It can combine multiple indicators of Shanghai OPM, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 19.9 M | 20.9 M | |
| Interest Income | 23.2 M | 12.1 M | |
| Operating Income | 35.9 M | 58.3 M | |
| Net Income From Continuing Ops | 53.3 M | 63.4 M | |
| Income Before Tax | 61.7 M | 71.8 M | |
| Net Income | 54 M | 63.7 M |
Shanghai Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Shanghai OPM. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shanghai OPM position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shanghai OPM's important profitability drivers and their relationship over time.
Use Shanghai OPM in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shanghai OPM position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai OPM will appreciate offsetting losses from the drop in the long position's value.Shanghai OPM Pair Trading
Shanghai OPM Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Shanghai OPM could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shanghai OPM when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shanghai OPM - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shanghai OPM Biosciences to buy it.
The correlation of Shanghai OPM is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shanghai OPM moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shanghai OPM Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shanghai OPM can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Shanghai OPM position
In addition to having Shanghai OPM in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Shanghai Stock
To fully project Shanghai OPM's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Shanghai OPM Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Shanghai OPM's income statement, its balance sheet, and the statement of cash flows.